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Abstract
Background: Pneumonia is the single largest cause of death in under-five children worldwide. We conducted a
systematic review to identify the knowledge gaps around childhood pneumonia in Bhutan.
Methods: We searched PubMed, ScienceDirect and Google scholar from conception to 3rd December 2018, World
Health Organization, UNICEF, Bhutan’s Ministry of Health and other local databases for relevant reports. We included
any report describing pneumonia in Bhutanese children with regards to the burden of the disease, aetiology,
related risk factors, clinical and prognostic characteristics, surveillance systems and national preventive strategies.
Two review authors identified the records. We summarized the findings narratively.
Results: We included 44 records. Although with notable decreasing trends, pneumonia is still accountable for a
high burden and mortality rate in Bhutanese children. The national surveillance system focuses mainly on influenza
identification but has recently introduced other viral aetiology to monitor. We found very scarce or no data with
regard to the bacterial aetiology, related risk factors and clinico-radiological and prognostic characteristics.
Conclusion: There is a dearth of data regarding the epidemiological, microbiological, clinical and radiological
characteristics of pneumonia in children in Bhutan, leading to challenges while implementing evidence-based
management and effective national preventive strategies.
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Background
In 2015, pneumonia was ranked as the single biggest
killer of post-neonatal children worldwide. With an esti-
mated 15·5% attributable fraction of all deaths in chil-
dren under 5 years of age, pneumonia is believed to be
responsible for the deaths of around 900,000 children
every year [1, 2]. The main burden remains dispropor-
tionately concentrated in low- and middle-income coun-
tries (LMIC) in Southeast Asia and sub-Saharan Africa,
where pneumonia is one of the most frequent triggers of
health facility consultation, and one of the most com-
mon causes of hospitalization, representing a huge load
for the overburdened and fragile health care systems [3].
The world has achieved considerable progress in redu-
cing child mortality in the last two decades [4], and re-
ductions in pneumonia-attributable mortality are partly
responsible for such a massive public health achievement
[1]. Various interventions have shown to be effective to
prevent and treat childhood pneumonia, including exclu-
sive breastfeeding for 6 months, prevention of childhood
malnutrition, childhood immunization, reduction of
household air pollution, hand washing, and use of simple
and standardized guidelines [5–7]. Although substantial
progress has been achieved, the toll of preventable
deaths related to pneumonia remains intolerably heavy.
Better implementation of the strategies shown to be ef-
fective to prevent and treat childhood pneumonia seems
crucial to further reduce the burden of pneumonia.
Once implemented, adequate national surveillance sys-
tems are required to evaluate their progress towards the
reduction of the disease burden. To this end, it is im-
perative to collect reliable local data to determine the
burden of the disease, the main pathogens involved, risk
factors contributing to the disease, and to describe epi-
demiological trends. However, reliable local data are
often scarce or entirely missing in LMIC, where the
main burden of pneumonia remains concentrated,
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leading to challenges when it comes to evaluating the
preventive strategies implemented [8].
Bhutan is a small country (38,394 km2) locked in the
Himalayas between India and China [9]. Elevation rises
from around 100 m to more than 7500, with the capital,
Thimphu, standing at 2334 m [10]. It is currently classi-
fied as a lower-middle income country [11]. The popula-
tion was estimated at 779,666 in 2017 and life
expectancy at birth was 70·6 years in 2016 [12, 13]. Two
thirds of the population live in rural areas [14]. Essential
health services in both modern and traditional medicines
are free for Bhutanese citizens, as guaranteed by the
Constitution, based on a primary health care approach
[15]. Health services are offered across the country
through secondary and tertiary level hospitals, basic
health units, subposts and outreach clinics [12].
The WHO-recommended Integrated Management of
Childhood Illnesses (IMCI) strategy was adopted and
implemented in Bhutan in 2000, as a strategy to address
the major causes of deaths in under-five children. Health
workers were trained across the country and the cover-
age of IMCI implementation reached 100% in all the dis-
tricts of the country by 2011 [16]. The strategy promotes
the early recognition of different syndromes (including
pneumonia) in under-five children, as well as a simple
and algorithm-based systematic approach for their man-
agement. Despite these efforts, acute respiratory infec-
tions (ARI) seem to remain a major public health
challenge in Bhutan, whereby they were estimated to
represent the fifth cause of mortality for the whole
population, and to cause 15% of deaths in under-five
children [12, 17]. The conjugate Haemophilus influenzae
type b (Hib) vaccine is routinely administered since 2011
and the pneumococcal conjugate vaccine was recently
introduced in the childhood immunization schedule
(January 2019) [18, 19]. Reduction of risk factors,
immunisation, and case management are the main
approaches to disease control [3].
Summarizing the available data on the epidemiology,
aetiology and clinical characteristics of pneumonia
among Bhutanese children would help to better under-
stand and characterize the impact of this major killer
and would allow the identification of knowledge gaps to
improve local tailored programmes to reduce the burden
and mortality associated with childhood pneumonia in
Bhutan.
Objectives
We conducted this systematic review in order to identify
the knowledge gaps around ARI in children in Bhutan.
We aimed to collect any available data with regards to
the burden of the disease, the aetiology, clinico-
radiological characteristics, the associated health deter-
minants and trends over the last years, as well as the
current surveillance systems and national preventive
strategies.
Methods
We followed the protocol established for this review
(Additional file 1: Appendix 1).
Selection criteria
We sought to include any study or primary report in
which participants were children under 5 years of age
(or all ages when disaggregated data were not available)
in Bhutan that would report data on ARI or pneumonia,
as defined by the study authors, regarding any of the
following:
 burden of the disease such as incidence, prevalence,
morbidity, mortality, or number of visits in health
facilities;
 aetiology;
 related risk factors;
 clinical and prognostic characteristics;
 management;
 existing surveillance systems;
 national preventive strategies related to ARI or
pneumonia.
We excluded documents when duplicated.
Definitions
The clinical case definition of pneumonia has been
changing over the last few decades [20, 21]. As of today,
there is no optimal gold standard definition available
[22]. Lower respiratory infections (LRI) is a broad term
that includes pneumonia and bronchiolitis, as defined in
the Global Burden of Diseases, Injuries, and Risk Factors
Study (GBD) [6]. This is the terminology we strived to
use in this review. However, we will report data as
defined by the study authors. Thereby, ARI is often used
and may imply here a broader concept including both
upper and lower respiratory infections.
Search methods for identification of studies
We attempted to identify all relevant reports regardless
of language or publication status (published, unpublished,
and in press).
Electronic searches
We conducted an electronic search of the following
databases, using the search terms and strategy described
in Additional file 1: Appendix 2. PubMed (1942 to 3
December 2018), ScienceDirect (1944 to 3 December
2018) and Google Scholar (up to December 2018). We
manually searched all the issues of the Bhutan Health
Journal for relevant publications (conception to
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December 2018). We searched databases of the WHO,
UNICEF, Ministry of Health in Bhutan, Royal Centre for
Disease Control (RCDC), National Statistics Bureau,
Jigme Dorji Wangchuck National Referral Hospital
(JDWNRH) and Khesar Gyalpo University of Medical
Sciences of Bhutan (KGUMSB) websites for relevant
documents.
Other sources
We manually searched the reference lists of all docu-
ments identified by the above methods that met our eli-
gibility criteria for other potentially relevant documents.
We looked for unpublished theses or other unpublished
documents at the libraries of the Faculty of Nursing and
Public Health and Faculty of Postgraduate Medicine at
KGUMSB in Thimphu, Bhutan. We contacted re-
searchers and key stakeholders at the Ministry of Health,
at the Microbiology Department at JDWNRH, and at
RCDC in Thimphu, to identify additional potentially
relevant unpublished data.
Data collection and analysis
Selection of studies
Two review authors (SJ and DP) independently screened
the titles and abstracts of the reports identified by the
electronic searches and identified in the reference lists of
selected documents or in the libraries cited above, to
identify eligibility criteria. Duplicate reports were re-
moved. We retrieved the full-text articles of the records
that were identified as potentially eligible. SJ and DP in-
dependently assessed the full-text articles for eligibility,
using the predefined inclusion and exclusion criteria,
and resolved any disagreements by discussion.
Data extraction, data management and data synthesis
SJ extracted data from the included records. DP checked
all extracted data to identify any possible errors. Data
describing study setting, population, methods and out-
comes as well as pneumonia definitions used by the
study authors were extracted. From other documents
and data identified from the screened websites, we ex-
tracted additional relevant data which were classified
under selected themes according to our outcomes of
interest. When available, we collected data for each out-
come on population characteristics, setting and method-
ology used. We synthesized the findings narratively with
the support of graphs and tables, under different themes.
We reorganised the themes based on the amount of in-
formation gathered for each of them.
Results
Results of the search
The database searches conducted up to 3rd December
2018 returned 714 records. The screening of titles and
abstracts revealed 11 relevant records, for which the full-
text article was retrieved. Five studies met our eligibility
criteria and were included in the review. We identified
40 additional reports related to the topic through other
electronic search and sources, out of which we excluded
one due to duplication. Overall, we included 44 docu-
ments for qualitative synthesis (Fig. 1). Included and
Fig. 1 Flow diagram illustrating the selection of records
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excluded records with reasons for exclusion are listed in
Additional file 1: Appendix 3.
We included 10 studies and 34 reports. All of them are
published except one unpublished report and one medical
thesis Tshering T: Incidence, risk factors, and outcome of
ventilator-associated pneumonia in pediatric intensive
care unit Jigme Dorji Wangchuk National Referral Hos-
pital. A prospective hospital-based study, (unpublished ob-
servations) (see Additional file 1: Appendix 3). The
medical thesis focuses on ventilator-associated pneumonia
(VAP) in children admitted at the national referral hos-
pital (JDWNRH), while all the other studies describe com-
munity acquired infections. Eight studies focused on
Bhutan, while two manuscripts presented data on LRI
in 195 countries including Bhutan [6, 23]. Nine out
of the 10 studies were published in the last 8 years;
the remaining one was published in 1995 [24]. Only two
studies [24, 25] focused on children, all other studies
included all age groups.
Surveillance systems for respiratory infections in Bhutan
No systematic national notifiable disease surveillance
system existed in Bhutan a decade ago, albeit a few noti-
fiable diseases were reported nationally [26]. Over the
last 10 years, the RCDC initiated an influenza surveil-
lance system among outpatients and hospitalized pa-
tients, comprising Influenza-Like Illness (ILI) and Severe
Acute Respiratory Infection (SARI). This clinical and
laboratory-based surveillance is carried out at 11 hospi-
tals that were selected as sentinel sites. Each sentinel site
collects random samples from few ILI cases every week,
and samples from every SARI case [27]. This system
works as epidemiological and virological surveillance,
with the aim of monitoring the burden and trends in re-
spiratory diseases, as well as monitoring the epidemi-
ology of influenza viruses and other respiratory
pathogens [28, 29]. Data are reported on a weekly basis
and feedbacks are shared on the RCDC website every
week and in quarterly bulletins [15, 28, 30]. Evaluation
of the SARI surveillance platform by Thapa et al. in
2015 and 2016 identified significant underreporting of
SARI cases, consequently questioning the national data
ensuing from this surveillance system [31].
Burden and seasonality patterns of acute respiratory
infections in Bhutan
We summarized the main findings on the burden of
ARIs in Bhutan in Additional file 1: Appendix 4, Table
4A.
The incidence of pneumonia in Bhutan has exhibited a
decreasing trend in the last 10 years, from 1479 cases
per 10,000 children under 5 years of age in 2008 to 809
in 2017 [12, 32]. Pneumonia cases, number of outpatient
visits attributed to pneumonia in hospitals and in basic
health units, and number of inpatients attributed to
pneumonia in under-five children have also decreased in
the last 10 years in term of both absolute and relative
numbers (Additional file 1: Appendix 4, Table 4B).
According to the quarterly bulletins published by
the RCDC, the national surveillance system reported
a total of 172,833 cases of respiratory illness in 2018
[30] Additional file 1: Appendix 4, Table 4C.
One study aimed to estimate influenza-associated respira-
tory hospitalization rates in Bhutan [31]. There were 11,782
hospital discharges coded with respiratory diagnosis in 2015
across Bhutan, and 13,697 in 2016. Six district hospitals iden-
tified as sentinel sites that were included in their analysis re-
ported 3138 respiratory hospitalizations, of which 45% were
among under-five children. The highest influenza-associated
hospitalization rates were found among children under five:
182 (95% CI: 153 to 210) and 532 (95% CI: 473 to 591) per
100,000 persons in 2015 and 2016, respectively.
Looking at the most updated available data, the influ-
enza sentinel surveillance reported 1214 cases of ILI per
10,000 hospital visits and 29 cases of SARI per 100
hospital admissions in 2018 [30] (Additional file 1:
Appendix 4, Table 4D).
Finally, one record looked at VAP in children admitted
in the paediatric intensive care unit in 2017. Out of the
92 included patients, 13 were diagnosed as VAP, result-
ing in VAP incidence of 14·1% and in VAP incidence
density of 44·9/1000 ventilator days.
Regarding the seasonality pattern of ARI, Fig. 2 shows
the number of ILI and SARI cases reported weekly in
the last 2 years. There are two main peaks each year,
around the weeks 20 and 35 in 2017 and around the
weeks 11 and 34 in 2018.
Mortality related to acute respiratory infections and
pneumonia in Bhutanese children
We summarized the main findings on the mortality
related to ARIs in Additional file 1: Appendix 5, Table
5A.
Since 2015, WHO ranked pneumonia as the leading
individual cause of under-five mortality worldwide, and
Bhutan is not an exception. In 2016 ARI was estimated
to be responsible for 15 and 27% of under-five and post-
neonatal deaths, respectively. Table 1 summarizes
changes in pneumonia-attributable mortality between
the years 2000 and 2016 globally and for Bhutan [2].
The GBD study estimated an increasing LRI mortality
rate from 51 to 80 per 100,000 under-five children in
2015 to 100 to 249 in 2016 [6, 23].
Focusing on data collected under the term “pneumonia”,
this disease was ranked as the fifth main cause of mortality
among the Bhutanese population in 2017 [12]. The esti-
mates of deaths for different major causes in Bhutanese
children between one and 59months of age showed a
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decline from 2000 to 2010 in the number of deaths attrib-
uted to pneumonia (See Additional file 1: Appendix 5,
Table 5B). However, pneumonia remains the single big-
gest cause of post-neonatal child deaths, causing 27·8% of
the overall number of deaths in 2010 [25]. A hospital-
based study conducted between 2009 and 2011 collected
causes of under-five mortality in Bhutan. Authors
reported that pneumonia accounted for 45% of deaths in
children from one to 59months, but underlined that their
analysis provided data on child mortality happening in
health facilities, which is likely to overestimate the true
value [25]. Finally, the scarce data available on VAP in
Bhutanese children describe five deaths (38·5%) out of the
13 cases of VAP included in the study.
Fig. 2 Number of ILI and SARI cases in 2017 and 2018. Reproduction permitted. Source: RCDC Fluview weekly reports [30]








Under 5 deaths due to ARI Post-neonatal death due to ARIa
Absolute number Rate
(per 1000 live births)
% Absolute number Rate
(per 1000 live births)
%
Global 2000 10,050,919 6,047,778 1,774,025 14 18 1,466,299 11 24
2016 5,649,439 3,036,996 878,829 6 16 719,413 5 24
Bhutan 2000 1280 768 278 17 22 242 15 32
2016 468 206 69 5 15 56 4 27
Abbreviations: ARI acute respiratory infections
aCalculated as (Under5 deaths due to ARI – neonatal deaths due to ARI)
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Aetiology of ARI
We found scarce data regarding the aetiology of ARI in
Bhutan, most of which focused on influenza virus,
mainly collected through the national surveillance sys-
tem. We identified one paper investigating Streptococcus
pneumoniae, and one thesis reporting on bacterial iso-
lates for VAP.
Wangchuk et al. summarized epidemiological data on
influenza from November 2008 to 2011, which includes
the pandemic influenza A(H1N1)pdm09 period [33]. In-
fluenza strains circulating prior to the pandemic period
included A/H1 and A/H3, with A (H1N1)pdm09
remaining a dominant strain for almost 1 year after the
pandemic period, when it was replaced by A/H3. Influ-
enza B was present throughout and after the pandemic
period. During the pandemic period, 2149 samples were
collected with results shown in Additional file 1: Appen-
dix 6, Table 6A.
The RCDC publishes “Fluview”, a weekly summary of
the ILI and SARI surveillance [30]. Every week, each of
the 11 hospitals identified as sentinel sites collect sam-
ples from between four and six cases of ILI, and from
each cases of SARI. The respiratory samples collected at
the sentinel sites are firstly tested by Real Time Polymer-
ase Chain Reaction for Flu A/H1, Flu A/H3, Flu A/
H5N1, Flu A/H7N9, Flu A/unsub and Flu B. For those
samples negative to any type of influenza, there is a fur-
ther attempt to identify respiratory syncytial virus (RSV)
and human metapneumovirus (HMPV). Recently, identi-
fication of further viruses also includes adenovirus and
parainfluenza viruses 1, 2 and 3, reported in the last two
quarterly bulletins (from mid 2018) (personal communi-
cation). In 2018, RSV was identified in a considerable
number of cases, while HMPV, adenovirus and para-
influenza viruses were isolated in few cases only [30].
Tshokey et al. presented the serotypes and antibiotic
susceptibility of S. pneumoniae isolates collected at the
JDWNRH in Thimphu in 2014 and 2015 [34]. Fifteen
different serotypes were identified out of 21 confirmed
pneumococcal isolates, collected from several sources
(five were from blood sample and two from sputum)
(Additional file 1: Appendix 6, Table 6B). Authors also
looked at the serotype coverage from the available
pneumococcal vaccines and calculated that the 7-valent
and 10-valent vaccines would cover 26·7% and 40·0% of
the identified serotypes respectively, while the 13-valent
and 23-valent would cover 53·3% of them.
Unpublished data provided by the Department of
Microbiology from the same hospital, JDWNRH in
Thimphu, described the number of pneumococcal iso-
lates and their antibiotic susceptibility in 2016. Only
nine isolates were identified from blood samples, and 12
from respiratory samples, all of them fully susceptible to
penicillin (Additional file 1: Appendix 6, Table 6C).
Finally, there were 18 bacterial isolates from endo-
tracheal aspirates of 13 children with VAP reported in
the medical thesis. Klebsiella spp. [8] and Escherichia
coli [4] were the most common pathogens identified,
followed by Acinetobacter spp. [2], Enterococcus [2], Sta-
philococcus aureus [2] and Pseudomonas spp. [1]. Anti-
biotic susceptibility was not reported for these bacterial
isolates.
Risk factors for ARI
One study published in 1995 described risk factors of
ARI [24]. This prospective cohort study of 113 children
born in 1990 found a statistically significant reduction in
the incidence of both diarrhoea and respiratory tract in-
fections associated with breastfeeding. Tashi and col-
leagues also looked at risk factors for prediction of VAP
among a limited number of patients. Amongst the med-
ical co-morbidities, disorders of the central nervous sys-
tem, trauma and sepsis were statistically significant in
the development of VAP.
The GBD study calculated modelling estimates in
under-five LRI mortality attributable to change in risk
factors between 2000 and 2016. In Bhutan, it was esti-
mated that changes related to childhood wasting, stunt-
ing and overweight have reduced LRI-related mortality
by 9·41%, 3·56% and 4·45% respectively. Similarly,
changes related to handwashing have reduced LRI-
related mortality by 0·38%, breastfeeding by 1·29%,
second-hand smoking by 0·23%, household air pollution
by 7·52%, adequate antibiotic treatment by 3·01%, zinc
deficiency by 0·29% and Hib vaccination by 6·44%. The
only assessed risk factor that was attributed to an in-
crease in LRI-related mortality was ambient particulate
matter pollution, with a 7·33% increase [6].
Clinico-radiological characteristics, prognosis and
management of ARI
We did not find any study describing the clinical or
radiological characteristics, prognosis and management
of Bhutanese children suffering from community-
acquired pneumonia or ARI. The only data available
suggest that in 2010, 74·2% of children under five with
suspected pneumonia were taken to an appropriate
healthcare provider, and that treatment with antibiotics
was given in 48·7% of the cases with suspected pneumo-
nia [35]. Tashi and colleagues presented 13 children with
VAP. Most of them had important co-morbidities,
including sepsis [7], congenital heart disease [6] and cen-
tral nervous system infection [5] as primary diagnosis.
The median duration of stay in the intensive care unit
was 28 days while it was 5 days for children without
VAP.
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National preventive strategies
Activities for ARI control were initiated in 1987. The
ARI Programme was instituted in the erstwhile Depart-
ment of Health in 1992 and activities were intensified in
1993 with the primary intention of reducing under-five
deaths due to pneumonia. WHO Standard Case Man-
agement Protocol for ARI was introduced in 1994, while
IMCI was implemented in 2000 [12].
In the report dedicated to the identification of under-
five deaths in health facilities in Bhutan, the Ministry of
Health supported by UNICEF recognised the need of
expanding the role of village health workers to provide
antibiotics for pneumonia in order to help reduce child
mortality attributable to sepsis and pneumonia [25].
Models were developed to estimate the impact of differ-
ent interventions for reducing the under-five mortality
rate, and so as to identify priority child health interven-
tions that would result in maximum impact. It was esti-
mated that oral antibiotics for the management of
pneumonia would contribute to prevent 16% of add-
itional deaths in under-five children [25].
A health economics analysis was conducted to deter-
mine the cost-utility of 10- and 13-valent pneumococcal
conjugate vaccines (PCV10 and PCV13) compared to no
vaccination in Bhutan [36]. It suggested that PCV13 and
PCV10 could prevent 30 and 18 deaths respectively in
the vaccinated population. If the proportion of the vacci-
nated population is over 80%, which is likely to be the
case in Bhutan, the indirect effect of the vaccine to the
unvaccinated population, known as herd protection,
could prevent 12 and 10 deaths for PCV13 and PCV10
respectively. Authors concluded that both PCVs would
be cost-effective in Bhutan, thus recommending their
inclusion in the immunization programme. This has
recently been approved by the Bhutanese government,
with PCV13 being introduced into the routine vacci-
nation programme in January 2019. The seasonal influ-
enza vaccine is not routinely recommended for at-risk
population. Thapa et al. recently published estimations
of the number of hospitalizations due to influenza with
the aim of informing the Ministry of Health of the
seasonal influenza vaccine could be assessed [31]. The
benefits of its introduction among recommended target
groups are currently being explored by the Bhutanese
government.
Discussion
According to national estimates, ARI and pneumonia are
a significant national public health concern in Bhutan. Al-
though pneumonia trends in this country have followed
the decreasing trends observed globally, ARI is still re-
sponsible for high hospitalisation rates and a significant
outpatient burden. Children under five are the most af-
fected group. This is of particular concern, as pneumonia
is the single predominant cause of death both in Bhutan
and worldwide in this age group. However, there is no ro-
bust and comprehensive data in Bhutan describing this ill-
ness. Indeed, we did not identify data that would provide a
thorough understanding on the aetiology of ARI in Bhu-
tanese children, nor help us characterize this syndrome
better. In addition to the scarcity of local data, global esti-
mates might be questionable. Indeed, GBD estimates
showed an increase in the LRI mortality rate from 51 to
80 per 100,000 under-five children in 2015 to 100 to 249
in 2016, which is unexpected and doubtful [6, 23]. There
were inconsistencies between different local sources with
respect to the trend of the burden and mortality of the
disease over the years.
Most of the data we identified regarding the aetiology
of ARI and pneumonia are from the national ILI and
SARI surveillance. This relatively new surveillance sys-
tem has made great efforts in the last decade, being able
to publish weekly epidemiological and virological data
from the whole country, through a sentinel surveillance
system. Up to now, identification of RSV, HMPV, adeno-
virus and parainfluenza viruses is attempted only for
samples negative for influenza virus. However, targeted
screening leads to underreporting of other pathogens,
and failure to adequately describe or identify mixed viral
infections, commonly occurring in ARI [37, 38]. This
issue has been detected and testing all viruses will soon
be performed in all the collected samples independently
of influenza identification (personal communication). In
spite of the moderately good performance of the
national surveillance system in place, underreporting
appears to be common, questioning therefore the accuracy
of the national data provided.
Overall, there is a lack of knowledge regarding the
causing pathogens of childhood pneumonia in Bhutan.
The national surveillance data showed an increased
number of ILI and SARI at the end of the cold season,
and during the monsoon. However, no studies were
found describing in detail the viral aetiology of ARI in
children, in spite of the importance that viruses are
known to play in the aetiology of ARI in this age group.
Additionally, data on the bacterial aetiology of ARI in
Bhutan are also very limited, coming from studies with
very low sample sizes [34], from a study on nosocomial
VAP, or from limited hospital-based microbiological sur-
veillance efforts. We did not find any study describing
other important causative pathogens of respiratory in-
fections in children such as Mycoplasma pneumoniae,
Chlamydia pneumoniae, and Legionella pneumophila.
We also did not find any study looking at other causes
of LRI-like syndrome in children, such as bronchitis,
which would fall under the terminology of pneumonia as
defined by the WHO. Some of these admissions could
be due to non-infectious causes such as hyperreactive
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airways and contribute to the burden of what is overall
classified under the broader umbrella of ARI. Altogether,
there are considerable knowledge gaps regarding the
aetiology of ARI in Bhutanese children that need to be
addressed in a well conducted prospective aetiological
study, as a better understanding of the causes of this
deadly syndrome, which is crucial for better and more
tailored management and preventive strategies. More-
over, comprehensive local data on resistance patterns of
causative agents is also needed to effectively design
antibiotic management and prevent the emergence and
spread of antimicrobial resistance.
Vaccines are possibly one of the greatest public health
tools and a well-established strategy to prevent pneumonia
and reduce the number of deaths attributed to this illness.
Immunization is free of charge for the Bhutanese popula-
tion. Overall, the country presents high immunization
coverage rates, over 95% since 2010, and estimated as
94·4% in 2017 [15]. We found no comprehensive data de-
scribing the circulating pneumococcal serotypes in the
Bhutanese population, and very limited data describing
the burden of pneumococcal diseases in Bhutanese chil-
dren. Following the recent introduction of PCV13 in the
routine immunization programme, it would be highly
recommended to monitor the impact of the vaccine. This
could be achieved through surveillance system or pro-
spective study to determine circulating pneumococcal se-
rotypes, to estimate the burden of the disease including
number of hospitalisations attributed to pneumonia and
pneumonia-related mortality, and to assess the interplay
between S. pneumoniae and viral respiratory infection.
With a small population of less than a million of per-
sons, an elevation ranging from 100 to 7500m with con-
sequent variety of climate, and a free health care system,
Bhutan presents considerable different characteristics
compared to the neighbouring countries. Elevation, cli-
mate, population density and free health care are all
likely to play a role on the epidemiology and aetiology of
childhood pneumonia. Therefore, although some data
could be extrapolated from neighbouring countries to
characterise this disease, we believe that local data are
required to fill the knowledge gap on pneumonia in
Bhutanese children, given the unique context of this
country.
Conclusions
To our knowledge, this is the first systematic review that
gathers evidence from a variety of sources on ARI and
pneumonia in Bhutanese children and their significant
importance in terms of attributable childhood morbidity
and mortality. This is a critical step for summarizing all
that is currently known about ARI in Bhutan based on
existing data, but also points out the many existing
knowledge gaps, which should be addressed so that this
syndrome can be better characterised as to its aetiology,
epidemiology, patients’ clinico-radiological characteris-
tics and prognostic factors. Data is needed at a national
level, as factors that influence the outcomes such as aeti-
ology and patient characteristics vary geographically. Ef-
forts should be made towards the development of
research strategies in order to identify causative agents
of pneumonia in Bhutan, as well as health determinants
and prognostic factors of the illness, so that adequate
control measures can be established in the country.
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